CDH1 and breast neoplasm: Loss of E-cadherin expression in breast tumors has been associated with genetic and epigenetic alterations, including truncating pathogenic variants in the CDH1 coding sequence, loss of heterozygosity, and methylation of the CDH1 promoter.